CONFERENCE PROGRAMME

Day 2 - 7th September 2010
Beyond Phage Display Technology:
Biopharmaceuticals and More

• Home
• Programme (with links to the presentations)
• Day one
• Day two
• Photos
• Biographies

Markus Enzelberger - VP, Head of Discovery Alliances and Technologies, MorphoSys AG, Germany
Design Follows Function: The Evolution of Combinatorial Antibody Libraries

Dario Neri - Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland
Curing Cancer with Antibody Derivatives

Ian Tomlinson - Senior VP, Biopharmaceuticals R&D, GlaxoSmithKline, UK
Putting Biopharmaceuticals on the GSK Map

Stefan Dübel - Director, Technical University of Braunschweig, Germany
Towards Proteome-Scale Antibody Selections

Tristan Vaughan - Senior Director, Lead Generation, Medimmune, UK
Phage Today, Phage Tomorrow

Kevin Johnson - Chief Executive Officer, PanGenetics BV, UK
What comes next is mainly more of the same...

Jim Marks - Professor of Anesthesia & Pharmaceutical Chemistry, San Francisco, USA

Trudi Veldman - Director, Biologics Generation, Abbott Bioresearch Center, USA
IL12p40 Antibody Generation, Development and Clinical Data

Discussion Forum: Perspective on the Next 20 Years